Form D · Other Health Care
AMBLYOTECH INC.
Phoenix, AZ · CIK 0001695495
Offering snapshot reported Jan 24, 2020 · SEC filing
- Reported sold
- $735K Indefinite offering
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 14, 2014 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$590,619 → $735,334
- Reported investors11 → 12
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 24, 2020 | Amendment | $735,334 | $144,715vs Jan 24, 2019 | 12 | SEC filing |
| Jan 24, 2019 | Amendment | $590,619 | $188,564vs Jan 24, 2018 | 11 | SEC filing |
| Jan 24, 2018 | Amendment | $402,055 | $201,911vs Jan 24, 2017 | 8 | SEC filing |
| Jan 24, 2017 | Initial | $200,144 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-279053
Source: Form D, filed Jan 24, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Berricotte | Director |
| Robert Derricotte | Director |
| Michael Hopson | Director |
| Joseph Koziak | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
77 East Missouri Avenue Unit 67
Phoenix, AZ, 85012
Phoenix, AZ, 85012